CSE1L, chromosome segregation 1 like, 1434

N. diseases: 163; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE Thus, CAS/Crk assembly serves as a "molecular switch" for the induction of cell migration and appears to contribute to the invasive property of tumors. 9472046 1998
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 GeneticVariation group BEFREE For image analysis, Feulgen-stained slides of tumor imprints and of disaggregated tumor cytospin preparations were evaluated with the CAS-200 image analyzer. 2047381 1991
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.090 Biomarker phenotype BEFREE CSE1L silence promoted apoptosis and inhibited cell proliferation and invasion. 31347172 2020
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.090 AlteredExpression phenotype BEFREE CSE1L downregulation triggered a reduction of cell proliferation and invasion ability, and an increase of apoptosis rate and cell sensitivity to ADR. 30144787 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.090 AlteredExpression phenotype BEFREE Overexpression of the YPEL3 gene inhibited the proliferation, migration, and invasion of the HT-29 and HCT-8 colonic adenocarcinoma cells, and inactivated the Wnt/β-catenin signaling pathway; treatment with the Wnt agonist, CAS 853220-52-7, reduced the inhibitory effects of YPEL3 overexpression on proliferation, migration, and invasion in vitro. 29988027 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.090 Biomarker phenotype BEFREE CAS is a docking protein downstream of the proto-oncogene Src with a role in invasion and metastasis of cancer cells. 28808245 2017
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.090 Biomarker phenotype BEFREE CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression. 23806821 2013
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.090 AlteredExpression phenotype BEFREE Expression profiling of ovarian cancer cells after CSE1L silencing showed that CSE1L was required for the expression of genes promoting invasion and metastasis. 23948303 2013
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.090 Biomarker phenotype BEFREE Neural precursor cell expressed, developmentally downregulated 9 (NEDD9) acts as a scaffold protein and belongs to a family of CAS (Crk-associated substrate) that regulates protein complexes controlling invasion and differentiation. 22447485 2012
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.090 Biomarker phenotype BEFREE Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer. 22450763 2012
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.090 Biomarker phenotype BEFREE Cas proteins mediate integrin-dependent signals at focal adhesions, regulating cell invasion and survival; at least one family member, HEF1, regulates mitosis. 18256281 2008
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.080 Biomarker group BEFREE Furthermore, the localization of CAS is mainly restricted in the nucleus in the lesions of normal human testicular tissue and cancer adjacent normal testicular tissue. 31140031 2019
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.080 GeneticVariation disease BEFREE In Kampala, Uganda, there are three sub-lineages of M. tuberculosis lineage 3 that cause disease of comparable severity with CAS-Dehli as the most prevalent. 31498808 2019
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.080 Biomarker disease BEFREE Available associated information on gender (n = 18,944), age (n = 16,968), drug resistance (n = 19,606), and HIV serology (n = 2673), allowed to draw some important conclusions on TB geo-epidemiology; e.g. a positive correlation exists between certain Mycobacterium tuberculosis lineages (such as CAS and Beijing) and drug resistance (p-value<.001), while other lineages (such as LAM, X, and BOV) are more frequently associated with HIV-positive serology (p-value<.001). 30593925 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.080 Biomarker group BEFREE CAS-viewer: web-based tool for splicing-guided integrative analysis of multi-omics cancer data. 29697367 2018
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.080 Biomarker disease BEFREE The objective of this study was to determine in vitro, the susceptibility patterns of M. tuberculosis Uganda family compared with Beijing and Delhi/CAS, other M. tuberculosis sub-lineages that also circulate in Uganda but are not as prevalent. 27097724 2016
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.080 Biomarker disease BEFREE The most frequent superfamily of M tuberculosis in clinical isolates was Delhi/CAS (142, 30.3%) followed by NEW-1 (127, 27%). 25340935 2015
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.080 Biomarker group BEFREE CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression. 23806821 2013
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.080 AlteredExpression group BEFREE The cellular apoptosis susceptibility gene CAS/CSE1L is overexpressed in cancer, although it was originally identified as a gene that renders cells vulnerable to apoptotic stimuli. 22389439 2012
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.080 Biomarker disease BEFREE Moreover, high congruence between the MIRU-VNTR-based and spoligotyping-based strain groupings suggests that CAS, EAI and Beijing are the predominant strain lineages in the Mumbai TB patient population. 22321730 2012
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.080 Biomarker disease BEFREE The most frequent M. tuberculosis lineage was Lineage 3 (CAS/Delhi) with 106 isolates (40.6%), followed by Lineage 2 (East-Asian lineage, includes Beijing genotype) with 84 isolates (32.2%), Lineage 4 (Euro-American lineage) with 41 (15.7%) isolates, and Lineage 1 (Indo-Oceanic lineage) with 30 isolates (11.5%). 23300635 2012
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.080 AlteredExpression group BEFREE The cellular apoptosis susceptibility (CSE1L/CAS) protein is a microtubule-associated protein that is highly expressed in cancer. 20688056 2010
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.080 Biomarker group BEFREE PPM1H controls cell cycle and proliferation of cancer cells potentially through dephosphorylation of CSE1L and might be a new target of anticancer drugs. 18059182 2008
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.080 Biomarker disease BEFREE Two STs; ST26 (CAS_Delhi) and ST1 (Beijing) represented 36.1% of the total M. tuberculosis population in eastern Uttar Pradesh, North India. 18372222 2008
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.080 Biomarker disease BEFREE The observed distribution of genotypes shows that principal genetic group 1 strains (EAI, Beijing, CAS, Afri, "Manu") is high (35.4%) suggesting an ancient evolutionary history of tuberculosis in Madagascar, in relation to the origin of peopling and the demographic history. 16168940 2005